217 related articles for article (PubMed ID: 26681038)
1. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
2. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB
Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275
[TBL] [Abstract][Full Text] [Related]
3. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
Hu H; Zhang L; Teng G; Wu Y; Chen Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
[TBL] [Abstract][Full Text] [Related]
4. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.
Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB
Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373
[TBL] [Abstract][Full Text] [Related]
5. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.
Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB
Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of rs712 polymorphism in a let-7 microRNA-binding of KRAS gene in breast cancer of a Mexican population.
Patricia Gallegos-Arreola M; Briseño Zuno CJ; Eduardo Figuera L; Zúñiga González GM; Perales Mederos CI; Puebla Pérez AM; Rosales Reynoso MA
J BUON; 2020; 25(1):176-181. PubMed ID: 32277629
[TBL] [Abstract][Full Text] [Related]
8. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis.
Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M
Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923
[TBL] [Abstract][Full Text] [Related]
9. KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population.
Sanaei S; Hashemi M; Eskandari E; Hashemi SM; Bahari G
Asian Pac J Cancer Prev; 2017 May; 18(5):1301-1305. PubMed ID: 28610418
[TBL] [Abstract][Full Text] [Related]
10. An let-7 KRAS rs712 polymorphism increases hepatocellular carcinoma risk.
Xiong D; Song YP; Xiong W; Liang YD
Genet Mol Res; 2015 Oct; 14(4):14050-5. PubMed ID: 26535719
[TBL] [Abstract][Full Text] [Related]
11. A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.
Kazmi HR; Chandra A; Kumar S; Satyam LK; Gupta A; Nigam J; Srivastava M; Mittal B
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2577-2583. PubMed ID: 27620744
[TBL] [Abstract][Full Text] [Related]
12. A single nucleotide polymorphism in the 3'-untranslated region of the KRAS gene disrupts the interaction with let-7a and enhances the metastatic potential of osteosarcoma cells.
Zhang S; Hou C; Li G; Zhong Y; Zhang J; Guo X; Li B; Bi Z; Shao M
Int J Mol Med; 2016 Sep; 38(3):919-26. PubMed ID: 27430246
[TBL] [Abstract][Full Text] [Related]
13. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer.
Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L
Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577
[TBL] [Abstract][Full Text] [Related]
14. rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population.
Jiang QH; Peng HX; Zhang Y; Tian P; Xi ZL; Chen H
Onco Targets Ther; 2015; 8():3041-5. PubMed ID: 26543374
[TBL] [Abstract][Full Text] [Related]
15. Association study of hsa-mir-603 rs11014002 polymorphism and risk of breast cancer in a sample of Iranian population.
Hashemi M; Sanaei S; Mashhadi MA; Hashemi SM; Taheri M; Ghavami S
Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):69-73. PubMed ID: 26718432
[TBL] [Abstract][Full Text] [Related]
16. Association of rs712 polymorphism in Kras gene 3'-luntranslated region and cancer risk: a meta-analysis.
Zhao WH; Qu XF; Xing ZG; Zhao LQ; Qin L; Lv C
J BUON; 2015; 20(1):309-16. PubMed ID: 25778332
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
[TBL] [Abstract][Full Text] [Related]
18. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
Chin LJ; Ratner E; Leng S; Zhai R; Nallur S; Babar I; Muller RU; Straka E; Su L; Burki EA; Crowell RE; Patel R; Kulkarni T; Homer R; Zelterman D; Kidd KK; Zhu Y; Christiani DC; Belinsky SA; Slack FJ; Weidhaas JB
Cancer Res; 2008 Oct; 68(20):8535-40. PubMed ID: 18922928
[TBL] [Abstract][Full Text] [Related]
19. Association of rs712 polymorphism in a let-7 microRNA-binding site of
Gallegos-Arreola MP; Zúñiga-González GM; Gómez-Mariscal K; Rosales-Reynoso MA; Luis L; Puebla-Pérez AM; Pineda-Razo T
Iran J Basic Med Sci; 2019 Mar; 22(3):324-327. PubMed ID: 31156795
[TBL] [Abstract][Full Text] [Related]
20. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
